{"transactions":[{"id":768653,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:11:24.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":34200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."}],"balance_after":34200,"derivative":{"underlying":"Common Stock","underlying_shares":34200},"source":{"system":"sec-edgar","filing":"0001669080-26-000003","document":"wk-form4_1779394282.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000166908026000003/wk-form4_1779394282.xml","form_type":"4"}},{"id":768652,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2026-05-21T20:11:24.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":41800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to vest 100% on May 20, 2027."}],"balance_after":41800,"derivative":{"exercise_price":1.23,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":41800},"source":{"system":"sec-edgar","filing":"0001669080-26-000003","document":"wk-form4_1779394282.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000166908026000003/wk-form4_1779394282.xml","form_type":"4"}},{"id":878006,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:44:20.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":972},"source":{"system":"sec-edgar","filing":"0001669080-26-000002","document":"wk-form4_1772228657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000166908026000002/wk-form4_1772228657.xml","form_type":"4"}},{"id":878005,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T21:44:20.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":972,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":87592,"source":{"system":"sec-edgar","filing":"0001669080-26-000002","document":"wk-form4_1772228657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000166908026000002/wk-form4_1772228657.xml","form_type":"4"}},{"id":1139356,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-21T20:57:10.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":false,"shares":2167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2167},"source":{"system":"sec-edgar","filing":"0001055726-25-000032","document":"wk-form4_1747861024.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000032/wk-form4_1747861024.xml","form_type":"4"}},{"id":1139355,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T20:57:10.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":true,"shares":2167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."}],"balance_after":86620,"source":{"system":"sec-edgar","filing":"0001055726-25-000032","document":"wk-form4_1747861024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000032/wk-form4_1747861024.xml","form_type":"4"}},{"id":1239099,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-02-28T23:05:18.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares will vest on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares will vest on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares will vest on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":972,"derivative":{"underlying":"Common Stock","underlying_shares":972},"source":{"system":"sec-edgar","filing":"0001055726-25-000001","document":"wk-form4_1740783911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000001/wk-form4_1740783911.xml","form_type":"4"}},{"id":1239098,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-02-28T23:05:18.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares vested on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares vested on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares vested on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":972},"source":{"system":"sec-edgar","filing":"0001055726-25-000001","document":"wk-form4_1740783911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000001/wk-form4_1740783911.xml","form_type":"4"}},{"id":1239097,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-28T23:05:18.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":972,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares will vest on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":84453,"source":{"system":"sec-edgar","filing":"0001055726-25-000001","document":"wk-form4_1740783911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000001/wk-form4_1740783911.xml","form_type":"4"}},{"id":1239096,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-28T23:05:18.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":972,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares vested on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":83481,"source":{"system":"sec-edgar","filing":"0001055726-25-000001","document":"wk-form4_1740783911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000001/wk-form4_1740783911.xml","form_type":"4"}},{"id":1505957,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-22T20:51:00.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":2167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 21, 2025."},{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 21, 2025."}],"balance_after":2167,"derivative":{"underlying":"Common Stock","underlying_shares":2167},"source":{"system":"sec-edgar","filing":"0001055726-24-000038","document":"wk-form4_1716411039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000038/wk-form4_1716411039.xml","form_type":"4"}},{"id":1505956,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-05-22T20:51:00.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":2917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to vest 100% on May 21, 2025."}],"balance_after":2917,"derivative":{"exercise_price":10.99,"expiration_date":"2034-05-21","underlying":"Common Stock","underlying_shares":2917},"source":{"system":"sec-edgar","filing":"0001055726-24-000038","document":"wk-form4_1716411039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000038/wk-form4_1716411039.xml","form_type":"4"}},{"id":1514761,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-16T21:05:26.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":false,"shares":2166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 15, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 15, 2024."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2166},"source":{"system":"sec-edgar","filing":"0001055726-24-000028","document":"wk-form4_1715893516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000028/wk-form4_1715893516.xml","form_type":"4"}},{"id":1514760,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T21:05:26.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":true,"shares":2166,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":82509,"source":{"system":"sec-edgar","filing":"0001055726-24-000028","document":"wk-form4_1715893516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000028/wk-form4_1715893516.xml","form_type":"4"}},{"id":1613116,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-02-28T22:10:29.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares will vest on February 26, 2025; and 972 shares will vest on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares will vest on February 26, 2025; and 972 shares will vest on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares will vest on February 26, 2025; and 972 shares will vest on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":1944,"derivative":{"underlying":"Common Stock","underlying_shares":972},"source":{"system":"sec-edgar","filing":"0001055726-24-000006","document":"wk-form4_1709158215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000006/wk-form4_1709158215.xml","form_type":"4"}},{"id":1613115,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-02-28T22:10:29.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":972,"derivative":{"underlying":"Common Stock","underlying_shares":972},"source":{"system":"sec-edgar","filing":"0001055726-24-000006","document":"wk-form4_1709158215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000006/wk-form4_1709158215.xml","form_type":"4"}},{"id":1613114,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-02-28T22:10:29.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units was as follows: 972 shares vested on February 26, 2022; 972 shares vested on February 26, 2023; and 972 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units was as follows: 972 shares vested on February 26, 2022; 972 shares vested on February 26, 2023; and 972 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units was as follows: 972 shares vested on February 26, 2022; 972 shares vested on February 26, 2023; and 972 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":972},"source":{"system":"sec-edgar","filing":"0001055726-24-000006","document":"wk-form4_1709158215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000006/wk-form4_1709158215.xml","form_type":"4"}},{"id":1613113,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T22:10:29.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":972,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2024; 972 shares will vest on February 26, 2025; and 972 shares will vest on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":80343,"source":{"system":"sec-edgar","filing":"0001055726-24-000006","document":"wk-form4_1709158215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000006/wk-form4_1709158215.xml","form_type":"4"}},{"id":1613112,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T22:10:29.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":972,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units is as follows: 972 shares vested on February 26, 2023; 972 shares vested on February 26, 2024; and 972 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":79371,"source":{"system":"sec-edgar","filing":"0001055726-24-000006","document":"wk-form4_1709158215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000006/wk-form4_1709158215.xml","form_type":"4"}},{"id":1613111,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T22:10:29.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":972,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 2,916 restricted stock units was as follows: 972 shares vested on February 26, 2022; 972 shares vested on February 26, 2023; and 972 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":78399,"source":{"system":"sec-edgar","filing":"0001055726-24-000006","document":"wk-form4_1709158215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000006/wk-form4_1709158215.xml","form_type":"4"}},{"id":1892081,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-05-16T20:54:55.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The restricted stock units will vest 100% on May 15, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The restricted stock units will vest 100% on May 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The restricted stock units will vest 100% on May 15, 2024."}],"balance_after":26000,"derivative":{"underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001055726-23-000037","document":"wk-form4_1684270484.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000037/wk-form4_1684270484.xml","form_type":"4"}},{"id":1892080,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2023-05-16T20:54:55.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to vest 100% on May 15, 2024."}],"balance_after":35000,"derivative":{"exercise_price":0.77,"expiration_date":"2033-05-15","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001055726-23-000037","document":"wk-form4_1684270484.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000037/wk-form4_1684270484.xml","form_type":"4"}},{"id":1892079,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-05-16T20:54:55.000Z","date":"2023-05-16","kind":"exercise","planned":false,"acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001055726-23-000037","document":"wk-form4_1684270484.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000037/wk-form4_1684270484.xml","form_type":"4"}},{"id":1892078,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-16T20:54:55.000Z","date":"2023-05-16","kind":"exercise","planned":false,"acquired":true,"shares":19000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023."}],"balance_after":929124,"source":{"system":"sec-edgar","filing":"0001055726-23-000037","document":"wk-form4_1684270484.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000037/wk-form4_1684270484.xml","form_type":"4"}},{"id":1957218,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-03-13T21:10:11.000Z","date":"2023-03-11","kind":"exercise","acquired":false,"shares":11666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; and 11,666 shares vested on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; and 11,666 shares vested on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; and 11,666 shares vested on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11666},"source":{"system":"sec-edgar","filing":"0001055726-23-000014","document":"wf-form4_167874179632291.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000014/wf-form4_167874179632291.xml","form_type":"4"}},{"id":1957217,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-13T21:10:11.000Z","date":"2023-03-13","kind":"sale","acquired":false,"shares":5833,"price":1.15,"value":6707.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 13, 2022."}],"balance_after":910124,"source":{"system":"sec-edgar","filing":"0001055726-23-000014","document":"wf-form4_167874179632291.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000014/wf-form4_167874179632291.xml","form_type":"4"}},{"id":1957216,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-13T21:10:11.000Z","date":"2023-03-11","kind":"exercise","acquired":true,"shares":11666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; and 11,666 shares vested on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":915957,"source":{"system":"sec-edgar","filing":"0001055726-23-000014","document":"wf-form4_167874179632291.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000014/wf-form4_167874179632291.xml","form_type":"4"}},{"id":1987890,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-02-28T22:40:24.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 27, 2023, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares will vest on February 26, 2024; 11,667 shares will vest on February 26, 2025; and 11,666 shares will vest on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 27, 2023, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares will vest on February 26, 2024; 11,667 shares will vest on February 26, 2025; and 11,666 shares will vest on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 27, 2023, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares will vest on February 26, 2024; 11,667 shares will vest on February 26, 2025; and 11,666 shares will vest on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001055726-23-000004","document":"wf-form4_167762396172703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000004/wf-form4_167762396172703.xml","form_type":"4"}},{"id":1987889,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2023-02-28T22:40:24.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting schedule for the 60,000 options is as follows: 15,000 shares vested on February 27, 2023; 15,000 shares will vest on February 26, 2024; 15,000 shares will vest on February 26, 2025; and 15,000 shares will vest on February 26, 2026."}],"balance_after":60000,"derivative":{"exercise_price":1.24,"exercise_date":"2023-02-27","expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001055726-23-000004","document":"wf-form4_167762396172703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000004/wf-form4_167762396172703.xml","form_type":"4"}},{"id":1987888,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-02-28T22:40:24.000Z","date":"2023-02-26","kind":"exercise","acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2022, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2023; 11,667 shares will vest on February 26, 2024; and 11,666 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2022, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2023; 11,667 shares will vest on February 26, 2024; and 11,666 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2022, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2023; 11,667 shares will vest on February 26, 2024; and 11,666 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":23333,"derivative":{"underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001055726-23-000004","document":"wf-form4_167762396172703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000004/wf-form4_167762396172703.xml","form_type":"4"}},{"id":1987887,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-02-28T22:40:24.000Z","date":"2023-02-26","kind":"exercise","acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2022; 11,667 shares vested on February 26, 2023; and 11,666 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2022; 11,667 shares vested on February 26, 2023; and 11,666 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2022; 11,667 shares vested on February 26, 2023; and 11,666 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":11666,"derivative":{"underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001055726-23-000004","document":"wf-form4_167762396172703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000004/wf-form4_167762396172703.xml","form_type":"4"}},{"id":1987886,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-28T22:40:24.000Z","date":"2023-02-27","kind":"sale","acquired":false,"shares":11668,"price":1.28,"value":14935.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 13, 2022."}],"balance_after":904291,"source":{"system":"sec-edgar","filing":"0001055726-23-000004","document":"wf-form4_167762396172703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000004/wf-form4_167762396172703.xml","form_type":"4"}},{"id":1987885,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-28T22:40:24.000Z","date":"2023-02-26","kind":"exercise","acquired":true,"shares":11667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2022, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2023; 11,667 shares will vest on February 26, 2024; and 11,666 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":915959,"source":{"system":"sec-edgar","filing":"0001055726-23-000004","document":"wf-form4_167762396172703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000004/wf-form4_167762396172703.xml","form_type":"4"}},{"id":1987884,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-28T22:40:24.000Z","date":"2023-02-26","kind":"exercise","acquired":true,"shares":11667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2022; 11,667 shares vested on February 26, 2023; and 11,666 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":904292,"source":{"system":"sec-edgar","filing":"0001055726-23-000004","document":"wf-form4_167762396172703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000004/wf-form4_167762396172703.xml","form_type":"4"}},{"id":2188391,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2022-08-11T20:15:42.000Z","date":"2022-08-11","kind":"exercise","acquired":false,"shares":11875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"shares","element":"transactionShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."}],"balance_after":11875,"derivative":{"exercise_price":2.16,"exercise_date":"2013-03-14","expiration_date":"2023-03-14","underlying":"Common Stock","underlying_shares":11875},"source":{"system":"sec-edgar","filing":"0001055726-22-000050","document":"wf-form4_166024891625374.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000050/wf-form4_166024891625374.xml","form_type":"4"}},{"id":2188390,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-11T20:15:42.000Z","date":"2022-08-11","kind":"sale","acquired":false,"shares":11875,"price":2.66,"value":31587.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $2.66 to $2.69, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":892625,"source":{"system":"sec-edgar","filing":"0001055726-22-000050","document":"wf-form4_166024891625374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000050/wf-form4_166024891625374.xml","form_type":"4"}},{"id":2188389,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-11T20:15:42.000Z","date":"2022-08-11","kind":"exercise","acquired":true,"shares":11875,"price":2.16,"value":25650.0,"ownership":{"direct":true},"balance_after":904500,"source":{"system":"sec-edgar","filing":"0001055726-22-000050","document":"wf-form4_166024891625374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000050/wf-form4_166024891625374.xml","form_type":"4"}},{"id":2268723,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2022-05-17T20:32:21.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This grant was made pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options to vest 100% on May 16, 2023."}],"balance_after":28000,"derivative":{"exercise_price":1.89,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001055726-22-000041","document":"wf-form4_165281944451001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000041/wf-form4_165281944451001.xml","form_type":"4"}},{"id":2268722,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-17T20:32:21.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 16, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"This grant was made pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 16, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 16, 2023."}],"balance_after":19000,"derivative":{"underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001055726-22-000041","document":"wf-form4_165281944451001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000041/wf-form4_165281944451001.xml","form_type":"4"}},{"id":2268721,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-17T20:32:21.000Z","date":"2022-05-13","kind":"exercise","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001055726-22-000041","document":"wf-form4_165281944451001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000041/wf-form4_165281944451001.xml","form_type":"4"}},{"id":2268720,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-17T20:32:21.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":9000,"price":1.95,"value":17550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer."}],"balance_after":892625,"source":{"system":"sec-edgar","filing":"0001055726-22-000041","document":"wf-form4_165281944451001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000041/wf-form4_165281944451001.xml","form_type":"4"}},{"id":2268719,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-17T20:32:21.000Z","date":"2022-05-13","kind":"exercise","acquired":true,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2022."}],"balance_after":901625,"source":{"system":"sec-edgar","filing":"0001055726-22-000041","document":"wf-form4_165281944451001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000041/wf-form4_165281944451001.xml","form_type":"4"}},{"id":2336145,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-03-14T20:41:07.000Z","date":"2022-03-11","kind":"exercise","acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; 11,666 shares will vest on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; 11,666 shares will vest on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; 11,666 shares will vest on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; 11,666 shares will vest on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":11666,"derivative":{"underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001055726-22-000021","document":"wf-form4_164729029489063.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000021/wf-form4_164729029489063.xml","form_type":"4"}},{"id":2336144,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-14T20:41:07.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":4083,"price":3.2,"value":13065.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These transactions were executed in multiple trades at prices ranging from $3.19 to $3.23, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":883625,"source":{"system":"sec-edgar","filing":"0001055726-22-000021","document":"wf-form4_164729029489063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000021/wf-form4_164729029489063.xml","form_type":"4"}},{"id":2336143,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-14T20:41:07.000Z","date":"2022-03-11","kind":"exercise","acquired":true,"shares":11667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; 11,666 shares will vest on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":887708,"source":{"system":"sec-edgar","filing":"0001055726-22-000021","document":"wf-form4_164729029489063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000021/wf-form4_164729029489063.xml","form_type":"4"}},{"id":2342468,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-03-09T21:05:24.000Z","date":"2022-03-08","kind":"exercise","acquired":false,"shares":11666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares vested on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares vested on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares vested on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares vested on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11666},"source":{"system":"sec-edgar","filing":"0001055726-22-000014","document":"wf-form4_164685990756495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000014/wf-form4_164685990756495.xml","form_type":"4"}},{"id":2342467,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-09T21:05:24.000Z","date":"2022-03-09","kind":"sale","acquired":false,"shares":4083,"price":3.33,"value":13596.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer."}],"balance_after":876041,"source":{"system":"sec-edgar","filing":"0001055726-22-000014","document":"wf-form4_164685990756495.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000014/wf-form4_164685990756495.xml","form_type":"4"}},{"id":2342466,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-09T21:05:24.000Z","date":"2022-03-08","kind":"exercise","acquired":true,"shares":11666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares vested on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":880124,"source":{"system":"sec-edgar","filing":"0001055726-22-000014","document":"wf-form4_164685990756495.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000014/wf-form4_164685990756495.xml","form_type":"4"}},{"id":2366352,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-03-01T23:51:22.000Z","date":"2022-02-26","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on February 26, 2023; 11,667 shares will vest on February 26, 2024; 11,666 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on February 26, 2023; 11,667 shares will vest on February 26, 2024; 11,666 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on February 26, 2023; 11,667 shares will vest on February 26, 2024; 11,666 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on February 26, 2023; 11,667 shares will vest on February 26, 2024; 11,666 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001055726-22-000013","document":"wf-form4_164617866156651.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000013/wf-form4_164617866156651.xml","form_type":"4"}},{"id":2366351,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2022-03-01T23:51:22.000Z","date":"2022-02-26","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting schedule for the 60,000 options is as follows: 15,000 shares vested on February 26, 2022; 15,000 shares will vest on February 26, 2023; 15,000 shares will vest on February 26, 2024; 15,000 shares will vest on February 26, 2025."}],"balance_after":60000,"derivative":{"exercise_price":3.22,"exercise_date":"2022-02-26","expiration_date":"2032-02-26","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001055726-22-000013","document":"wf-form4_164617866156651.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000013/wf-form4_164617866156651.xml","form_type":"4"}},{"id":2366350,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-03-01T23:51:22.000Z","date":"2022-02-26","kind":"exercise","acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on February 26, 2022; 11,667 shares will vest on February 26, 2023; 11,666 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on February 26, 2022; 11,667 shares will vest on February 26, 2023; 11,666 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on February 26, 2022; 11,667 shares will vest on February 26, 2023; 11,666 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on February 26, 2022; 11,667 shares will vest on February 26, 2023; 11,666 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":23333,"derivative":{"underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001055726-22-000013","document":"wf-form4_164617866156651.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000013/wf-form4_164617866156651.xml","form_type":"4"}},{"id":2366349,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-01T23:51:22.000Z","date":"2022-02-26","kind":"exercise","acquired":true,"shares":11667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on February 26, 2022; 11,667 shares will vest on February 26, 2023; 11,666 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":868458,"source":{"system":"sec-edgar","filing":"0001055726-22-000013","document":"wf-form4_164617866156651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000013/wf-form4_164617866156651.xml","form_type":"4"}},{"id":2710794,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-05-17T20:27:30.000Z","date":"2021-05-14","kind":"exercise","acquired":false,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  These restricted stock units vested 100% on May 14, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  These restricted stock units vested 100% on May 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  These restricted stock units vested 100% on May 14, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0001055726-21-000045","document":"wf-form4_162128322950395.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000045/wf-form4_162128322950395.xml","form_type":"4"}},{"id":2710793,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-05-17T20:27:30.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 13, 2022."},{"field":"shares","element":"transactionShares","label":"F3","text":"This grant was made pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 13, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 13, 2022."}],"balance_after":18000,"derivative":{"underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001055726-21-000045","document":"wf-form4_162128322950395.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000045/wf-form4_162128322950395.xml","form_type":"4"}},{"id":2710792,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2021-05-17T20:27:30.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This grant was made pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options to vest 100% on May 13, 2022."}],"balance_after":27000,"derivative":{"exercise_price":6.23,"expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001055726-21-000045","document":"wf-form4_162128322950395.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000045/wf-form4_162128322950395.xml","form_type":"4"}},{"id":2710791,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-17T20:27:30.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":3045,"price":6.62,"value":20157.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer."}],"balance_after":856791,"source":{"system":"sec-edgar","filing":"0001055726-21-000045","document":"wf-form4_162128322950395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000045/wf-form4_162128322950395.xml","form_type":"4"}},{"id":2710790,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-17T20:27:30.000Z","date":"2021-05-14","kind":"exercise","acquired":true,"shares":8700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  These restricted stock units vested 100% on May 14, 2021."}],"balance_after":859836,"source":{"system":"sec-edgar","filing":"0001055726-21-000045","document":"wf-form4_162128322950395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000045/wf-form4_162128322950395.xml","form_type":"4"}},{"id":2743338,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2021-04-21T21:03:08.000Z","date":"2021-04-21","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"shares","element":"transactionShares","label":"F4","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."}],"balance_after":0,"derivative":{"exercise_price":2.4,"exercise_date":"2012-02-23","expiration_date":"2022-02-23","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001055726-21-000036","document":"wf-form4_161903896320284.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000036/wf-form4_161903896320284.xml","form_type":"4"}},{"id":2743337,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T21:03:08.000Z","date":"2021-04-21","kind":"sale","acquired":false,"shares":4083,"price":8.54,"value":34868.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer."}],"balance_after":851136,"source":{"system":"sec-edgar","filing":"0001055726-21-000036","document":"wf-form4_161903896320284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000036/wf-form4_161903896320284.xml","form_type":"4"}},{"id":2743336,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T21:03:08.000Z","date":"2021-04-21","kind":"sale","acquired":false,"shares":22500,"price":8.57,"value":192825.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $8.49 to $8.66, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":855219,"source":{"system":"sec-edgar","filing":"0001055726-21-000036","document":"wf-form4_161903896320284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000036/wf-form4_161903896320284.xml","form_type":"4"}},{"id":2743335,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T21:03:08.000Z","date":"2021-04-21","kind":"exercise","acquired":true,"shares":22500,"price":2.4,"value":54000.0,"ownership":{"direct":true},"balance_after":877719,"source":{"system":"sec-edgar","filing":"0001055726-21-000036","document":"wf-form4_161903896320284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000036/wf-form4_161903896320284.xml","form_type":"4"}},{"id":2792723,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-03-12T23:34:17.000Z","date":"2021-03-11","kind":"exercise","acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 11, 2021; 11,667 shares will vest on March 11, 2022; 11,666 shares will vest on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 11, 2021; 11,667 shares will vest on March 11, 2022; 11,666 shares will vest on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 11, 2021; 11,667 shares will vest on March 11, 2022; 11,666 shares will vest on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 11, 2021; 11,667 shares will vest on March 11, 2022; 11,666 shares will vest on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":23333,"derivative":{"underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001055726-21-000025","document":"wf-form4_161559204229772.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000025/wf-form4_161559204229772.xml","form_type":"4"}},{"id":2792722,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-12T23:34:17.000Z","date":"2021-03-11","kind":"exercise","acquired":true,"shares":11667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 11, 2021; 11,667 shares will vest on March 11, 2022; 11,666 shares will vest on March 11, 2023.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":855219,"source":{"system":"sec-edgar","filing":"0001055726-21-000025","document":"wf-form4_161559204229772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000025/wf-form4_161559204229772.xml","form_type":"4"}},{"id":2800867,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-03-10T00:03:30.000Z","date":"2021-03-08","kind":"exercise","acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":11666,"derivative":{"underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001055726-21-000020","document":"wf-form4_161533459312789.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000020/wf-form4_161533459312789.xml","form_type":"4"}},{"id":2800866,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-03-10T00:03:30.000Z","date":"2021-03-05","kind":"exercise","acquired":false,"shares":11666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 5, 2019; 11,667 shares vested on March 5, 2020; 11,666 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 5, 2019; 11,667 shares vested on March 5, 2020; 11,666 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 5, 2019; 11,667 shares vested on March 5, 2020; 11,666 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 5, 2019; 11,667 shares vested on March 5, 2020; 11,666 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11666},"source":{"system":"sec-edgar","filing":"0001055726-21-000020","document":"wf-form4_161533459312789.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000020/wf-form4_161533459312789.xml","form_type":"4"}},{"id":2800865,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T00:03:30.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":3500,"price":9.6003,"value":33601.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of restricted stock units granted by the issuer."}],"balance_after":843552,"source":{"system":"sec-edgar","filing":"0001055726-21-000020","document":"wf-form4_161533459312789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000020/wf-form4_161533459312789.xml","form_type":"4"}},{"id":2800864,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T00:03:30.000Z","date":"2021-03-08","kind":"exercise","acquired":true,"shares":11667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 8, 2020; 11,667 shares vested on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":847052,"source":{"system":"sec-edgar","filing":"0001055726-21-000020","document":"wf-form4_161533459312789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000020/wf-form4_161533459312789.xml","form_type":"4"}},{"id":2800863,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T00:03:30.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":3500,"price":9.1814,"value":32134.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of restricted stock units granted by the issuer."}],"balance_after":835385,"source":{"system":"sec-edgar","filing":"0001055726-21-000020","document":"wf-form4_161533459312789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000020/wf-form4_161533459312789.xml","form_type":"4"}},{"id":2800862,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T00:03:30.000Z","date":"2021-03-05","kind":"exercise","acquired":true,"shares":11666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 5, 2019; 11,667 shares vested on March 5, 2020; 11,666 shares vested on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":838885,"source":{"system":"sec-edgar","filing":"0001055726-21-000020","document":"wf-form4_161533459312789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000020/wf-form4_161533459312789.xml","form_type":"4"}},{"id":2830321,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-02-27T00:10:27.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on February 26, 2022; 11,667 shares will vest on February 26, 2023; 11,666 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on February 26, 2022; 11,667 shares will vest on February 26, 2023; 11,666 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on February 26, 2022; 11,667 shares will vest on February 26, 2023; 11,666 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001055726-21-000015","document":"wf-form4_161438459117474.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000015/wf-form4_161438459117474.xml","form_type":"4"}},{"id":2830320,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2021-02-27T00:10:27.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 60,000 options is as follows: 15,000 shares vested on February 26, 2021; 15,000 shares will vest on February 26, 2022; 15,000 shares will vest on February 26, 2023; 15,000 shares will vest on February 26, 2024."}],"balance_after":60000,"derivative":{"exercise_price":11.1,"exercise_date":"2021-02-26","expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001055726-21-000015","document":"wf-form4_161438459117474.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000015/wf-form4_161438459117474.xml","form_type":"4"}},{"id":2940631,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2020-12-18T00:06:01.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"shares","element":"transactionShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014."}],"balance_after":0,"derivative":{"exercise_price":4.56,"exercise_date":"2011-03-11","expiration_date":"2021-03-11","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001055726-20-000055","document":"wf-form4_160824994521394.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000055/wf-form4_160824994521394.xml","form_type":"4"}},{"id":2940630,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T00:06:01.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":17500,"price":10.7058,"value":187351.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $10.54 to $10.83, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":827219,"source":{"system":"sec-edgar","filing":"0001055726-20-000055","document":"wf-form4_160824994521394.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000055/wf-form4_160824994521394.xml","form_type":"4"}},{"id":2940629,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-18T00:06:01.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":17500,"price":4.56,"value":79800.0,"ownership":{"direct":true},"balance_after":844719,"source":{"system":"sec-edgar","filing":"0001055726-20-000055","document":"wf-form4_160824994521394.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000055/wf-form4_160824994521394.xml","form_type":"4"}},{"id":3147674,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-05-15T20:10:10.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 14, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 14, 2021."}],"balance_after":8700,"derivative":{"underlying":"Common Stock","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0001055726-20-000039","document":"wf-form4_158957339225846.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000039/wf-form4_158957339225846.xml","form_type":"4"}},{"id":3147673,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2020-05-15T20:10:10.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to vest 100% on May 14, 2021."}],"balance_after":13300,"derivative":{"exercise_price":13.65,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":13300},"source":{"system":"sec-edgar","filing":"0001055726-20-000039","document":"wf-form4_158957339225846.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000039/wf-form4_158957339225846.xml","form_type":"4"}},{"id":3153143,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-12T20:26:21.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":2404,"price":11.84,"value":28463.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer."}],"balance_after":827219,"source":{"system":"sec-edgar","filing":"0001055726-20-000033","document":"wf-form4_158931516303073.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000033/wf-form4_158931516303073.xml","form_type":"4"}},{"id":3156781,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-05-08T22:19:39.000Z","date":"2020-05-08","kind":"exercise","acquired":false,"shares":8013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 8, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 8, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8013},"source":{"system":"sec-edgar","filing":"0001055726-20-000026","document":"wf-form4_158897636187851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000026/wf-form4_158897636187851.xml","form_type":"4"}},{"id":3156780,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T22:19:39.000Z","date":"2020-05-08","kind":"exercise","acquired":true,"shares":8013,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 8, 2020."}],"balance_after":829623,"source":{"system":"sec-edgar","filing":"0001055726-20-000026","document":"wf-form4_158897636187851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000026/wf-form4_158897636187851.xml","form_type":"4"}},{"id":3213969,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2020-03-12T20:40:17.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting schedule for the 60,000 options is as follows: 15,000 shares vested on March 11, 2020; 15,000 shares will vest on March 11, 2021; 15,000 shares will vest on March 11, 2022; 15,000 shares will vest on March 11, 2023."}],"balance_after":60000,"derivative":{"exercise_price":8.37,"exercise_date":"2020-03-11","expiration_date":"2030-03-11","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001055726-20-000013","document":"wf-form4_158404559933910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/wf-form4_158404559933910.xml","form_type":"4"}},{"id":3213968,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-03-12T20:40:17.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on March 11, 2021; 11,667 shares will vest on March 11, 2022; 11,666 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on March 11, 2021; 11,667 shares will vest on March 11, 2022; 11,666 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on March 11, 2021; 11,667 shares will vest on March 11, 2022; 11,666 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001055726-20-000013","document":"wf-form4_158404559933910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/wf-form4_158404559933910.xml","form_type":"4"}},{"id":3213967,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-03-12T20:40:17.000Z","date":"2020-03-10","kind":"exercise","acquired":false,"shares":11666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 10, 2018; 11,667 shares vested on March 10, 2019; 11,666 shares vested on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 10, 2018; 11,667 shares vested on March 10, 2019; 11,666 shares vested on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 10, 2018; 11,667 shares vested on March 10, 2019; 11,666 shares vested on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 10, 2018; 11,667 shares vested on March 10, 2019; 11,666 shares vested on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11666},"source":{"system":"sec-edgar","filing":"0001055726-20-000013","document":"wf-form4_158404559933910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/wf-form4_158404559933910.xml","form_type":"4"}},{"id":3213966,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:17.000Z","date":"2020-03-12","kind":"sale","acquired":false,"shares":3500,"price":11.14,"value":38990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer."}],"balance_after":821610,"source":{"system":"sec-edgar","filing":"0001055726-20-000013","document":"wf-form4_158404559933910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/wf-form4_158404559933910.xml","form_type":"4"}},{"id":3213965,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:17.000Z","date":"2020-03-10","kind":"sale","acquired":false,"shares":3500,"price":9.32,"value":32620.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer."}],"balance_after":825110,"source":{"system":"sec-edgar","filing":"0001055726-20-000013","document":"wf-form4_158404559933910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/wf-form4_158404559933910.xml","form_type":"4"}},{"id":3213964,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T20:40:17.000Z","date":"2020-03-10","kind":"exercise","acquired":true,"shares":11666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 10, 2018; 11,667 shares vested on March 10, 2019; 11,666 shares vested on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":828610,"source":{"system":"sec-edgar","filing":"0001055726-20-000013","document":"wf-form4_158404559933910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/wf-form4_158404559933910.xml","form_type":"4"}},{"id":3221042,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-03-09T20:20:11.000Z","date":"2020-03-08","kind":"exercise","acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares  vested on March 8, 2020; 11,667 shares will vest on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares  vested on March 8, 2020; 11,667 shares will vest on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares  vested on March 8, 2020; 11,667 shares will vest on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares  vested on March 8, 2020; 11,667 shares will vest on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":23333,"derivative":{"underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001055726-20-000009","document":"wf-form4_158378519401805.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/wf-form4_158378519401805.xml","form_type":"4"}},{"id":3221041,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-03-09T20:20:11.000Z","date":"2020-03-05","kind":"exercise","acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 5, 2019; 11,667 shares vested on March 5, 2020; 11,666 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 5, 2019; 11,667 shares vested on March 5, 2020; 11,666 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 5, 2019; 11,667 shares vested on March 5, 2020; 11,666 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 5, 2019; 11,667 shares vested on March 5, 2020; 11,666 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":11666,"derivative":{"underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001055726-20-000009","document":"wf-form4_158378519401805.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/wf-form4_158378519401805.xml","form_type":"4"}},{"id":3221040,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-09T20:20:11.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":3500,"price":18,"value":63000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer."}],"balance_after":816944,"source":{"system":"sec-edgar","filing":"0001055726-20-000009","document":"wf-form4_158378519401805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/wf-form4_158378519401805.xml","form_type":"4"}},{"id":3221039,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-09T20:20:11.000Z","date":"2020-03-08","kind":"exercise","acquired":true,"shares":11667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares  vested on March 8, 2020; 11,667 shares will vest on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":820444,"source":{"system":"sec-edgar","filing":"0001055726-20-000009","document":"wf-form4_158378519401805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/wf-form4_158378519401805.xml","form_type":"4"}},{"id":3221038,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-09T20:20:11.000Z","date":"2020-03-05","kind":"exercise","acquired":true,"shares":11667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 5, 2019; 11,667 shares vested on March 5, 2020; 11,666 shares will vest on March 5, 2021.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":808777,"source":{"system":"sec-edgar","filing":"0001055726-20-000009","document":"wf-form4_158378519401805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/wf-form4_158378519401805.xml","form_type":"4"}},{"id":3449736,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-02T21:00:32.000Z","date":"2019-08-01","kind":"sale","acquired":false,"shares":16352,"price":2.72,"value":44477.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 12, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.70 to $2.75, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":797110,"source":{"system":"sec-edgar","filing":"0001055726-19-000049","document":"wf-form4_156477961645379.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000049/wf-form4_156477961645379.xml","form_type":"4"}},{"id":3530251,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-05-13T19:58:22.000Z","date":"2019-05-11","kind":"exercise","acquired":false,"shares":8170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8170},"source":{"system":"sec-edgar","filing":"0001055726-19-000038","document":"wf-form4_155777748753530.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000038/wf-form4_155777748753530.xml","form_type":"4"}},{"id":3530250,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T19:58:22.000Z","date":"2019-05-11","kind":"exercise","acquired":true,"shares":8170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019."}],"balance_after":813462,"source":{"system":"sec-edgar","filing":"0001055726-19-000038","document":"wf-form4_155777748753530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000038/wf-form4_155777748753530.xml","form_type":"4"}},{"id":3533931,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-05-09T22:00:49.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":8013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 8, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 8, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 8, 2020."}],"balance_after":8013,"derivative":{"underlying":"Common Stock","underlying_shares":8013},"source":{"system":"sec-edgar","filing":"0001055726-19-000030","document":"wf-form4_155743923408973.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000030/wf-form4_155743923408973.xml","form_type":"4"}},{"id":3533930,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2019-05-09T22:00:49.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to vest with respect to 100% of the shares on May 8, 2020."}],"balance_after":12500,"derivative":{"exercise_price":3.9,"expiration_date":"2029-05-08","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001055726-19-000030","document":"wf-form4_155743923408973.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000030/wf-form4_155743923408973.xml","form_type":"4"}},{"id":3599970,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-03-12T21:05:32.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on March 8, 2020; 11,667 shares will vest on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on March 8, 2020; 11,667 shares will vest on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares will vest on March 8, 2020; 11,667 shares will vest on March 8, 2021; 11,666 shares will vest on March 8, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001055726-19-000013","document":"wf-form4_155242471665422.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/wf-form4_155242471665422.xml","form_type":"4"}},{"id":3599969,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option","published_at":"2019-03-12T21:05:32.000Z","date":"2019-03-08","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting schedule for the 60,000 options is as follows: 15,000 shares vested on March 8, 2019; 15,000 shares will vest on March 8, 2020; 15,000 shares will vest on March 8, 2021; 15,000 shares will vest on March 8, 2022."}],"balance_after":60000,"derivative":{"exercise_price":3.34,"exercise_date":"2019-03-08","expiration_date":"2029-03-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001055726-19-000013","document":"wf-form4_155242471665422.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/wf-form4_155242471665422.xml","form_type":"4"}},{"id":3599968,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-03-12T21:05:32.000Z","date":"2019-03-10","kind":"exercise","acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 10, 2018; 11,667 shares vested on March 10, 2019; 11,666 shares will vest on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 10, 2018; 11,667 shares vested on March 10, 2019; 11,666 shares will vest on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 10, 2018; 11,667 shares vested on March 10, 2019; 11,666 shares will vest on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 35,000 restricted stock units is as follows: 11,667 shares vested on March 10, 2018; 11,667 shares vested on March 10, 2019; 11,666 shares will vest on March 10, 2020.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":11666,"derivative":{"underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0001055726-19-000013","document":"wf-form4_155242471665422.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/wf-form4_155242471665422.xml","form_type":"4"}},{"id":3599967,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-03-12T21:05:32.000Z","date":"2019-03-09","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 30,000 restricted stock units is as follows: 10,000 shares vested on March 9, 2017; 10,000 shares vested on March 9, 2018; 10,000 shares vested on March 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 30,000 restricted stock units is as follows: 10,000 shares vested on March 9, 2017; 10,000 shares vested on March 9, 2018; 10,000 shares vested on March 9, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 30,000 restricted stock units is as follows: 10,000 shares vested on March 9, 2017; 10,000 shares vested on March 9, 2018; 10,000 shares vested on March 9, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 30,000 restricted stock units is as follows: 10,000 shares vested on March 9, 2017; 10,000 shares vested on March 9, 2018; 10,000 shares vested on March 9, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001055726-19-000013","document":"wf-form4_155242471665422.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/wf-form4_155242471665422.xml","form_type":"4"}},{"id":3599966,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-03-12T21:05:32.000Z","date":"2019-03-09","kind":"exercise","acquired":false,"shares":5333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 16,000 restricted stock units was as follows: 5,334 shares vested on March 9, 2017; 5,333 shares vested on March 9, 2018; 5,333 shares vested on March 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 16,000 restricted stock units was as follows: 5,334 shares vested on March 9, 2017; 5,333 shares vested on March 9, 2018; 5,333 shares vested on March 9, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 16,000 restricted stock units was as follows: 5,334 shares vested on March 9, 2017; 5,333 shares vested on March 9, 2018; 5,333 shares vested on March 9, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 16,000 restricted stock units was as follows: 5,334 shares vested on March 9, 2017; 5,333 shares vested on March 9, 2018; 5,333 shares vested on March 9, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5333},"source":{"system":"sec-edgar","filing":"0001055726-19-000013","document":"wf-form4_155242471665422.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/wf-form4_155242471665422.xml","form_type":"4"}}],"next_cursor":"2019-03-12T21:05:32.000000Z,3599966"}